ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
aboo
|
1.3K |
321K |
9 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
1.3K
|
321K
|
9
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
aboo
|
1.3K |
321K |
18 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
1.3K
|
321K
|
18
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
aboo
|
261 |
62K |
21 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
261
|
62K
|
21
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
aboo
|
261 |
62K |
15 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
261
|
62K
|
15
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
aboo
|
261 |
62K |
10 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
261
|
62K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
aboo
|
261 |
62K |
10 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
261
|
62K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
aboo
|
261 |
62K |
3 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
261
|
62K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
aboo
|
261 |
62K |
8 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
261
|
62K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
aboo
|
261 |
62K |
3 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
261
|
62K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
aboo
|
261 |
62K |
5 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
261
|
62K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Allan Border
|
|
aboo
|
12 |
2.6K |
1 |
13/04/24 |
13/04/24 |
ASX - By Stock
|
12
|
2.6K
|
1
|
|
ASX - By Stock
|
PAA |
Allan Border
|
|
aboo
|
12 |
2.6K |
15 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
12
|
2.6K
|
15
|
|
ASX - By Stock
|
PAA |
Re:
Top 200 PAA Shareholders as at 28 March 2024
|
|
aboo
|
55 |
14K |
5 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
55
|
14K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
NZT gone but hasn't forgotten
|
|
aboo
|
66 |
18K |
2 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
66
|
18K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Media clarification
|
|
aboo
|
62 |
16K |
22 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
62
|
16K
|
22
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
aboo
|
196 |
36K |
6 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
196
|
36K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Top 200 PAA Shareholders as at 28 March 2024
|
|
aboo
|
55 |
14K |
10 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
55
|
14K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
aboo
|
58 |
17K |
7 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
58
|
17K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Mainstream media is GO
|
|
aboo
|
31 |
11K |
4 |
30/03/24 |
30/03/24 |
ASX - By Stock
|
31
|
11K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Mainstream media is GO
|
|
aboo
|
31 |
11K |
32 |
30/03/24 |
30/03/24 |
ASX - By Stock
|
31
|
11K
|
32
|
|
ASX - By Stock
|
PAA |
Mainstream media is GO
|
|
aboo
|
31 |
11K |
23 |
30/03/24 |
30/03/24 |
ASX - By Stock
|
31
|
11K
|
23
|
|
ASX - By Stock
|
PAA |
Re:
what odds of house deposit
|
|
aboo
|
14 |
3.5K |
21 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
14
|
3.5K
|
21
|
|
ASX - By Stock
|
PAA |
Re:
PAA Chart
|
|
aboo
|
282 |
74K |
3 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
282
|
74K
|
3
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
aboo
|
1.3K |
321K |
5 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
1.3K
|
321K
|
5
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
aboo
|
1.3K |
321K |
1 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
1.3K
|
321K
|
1
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
aboo
|
1.3K |
321K |
21 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
1.3K
|
321K
|
21
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
aboo
|
1.3K |
321K |
13 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
1.3K
|
321K
|
13
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
aboo
|
1.3K |
321K |
7 |
10/03/24 |
10/03/24 |
ASX - By Stock
|
1.3K
|
321K
|
7
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
aboo
|
1.3K |
321K |
2 |
10/03/24 |
10/03/24 |
ASX - By Stock
|
1.3K
|
321K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
aboo
|
317 |
79K |
8 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
317
|
79K
|
8
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
aboo
|
1.3K |
321K |
1 |
06/03/24 |
06/03/24 |
ASX - By Stock
|
1.3K
|
321K
|
1
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
aboo
|
1.3K |
321K |
11 |
06/03/24 |
06/03/24 |
ASX - By Stock
|
1.3K
|
321K
|
11
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
aboo
|
1.3K |
321K |
12 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
1.3K
|
321K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
aboo
|
317 |
79K |
7 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
317
|
79K
|
7
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
aboo
|
1.3K |
321K |
15 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
1.3K
|
321K
|
15
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
aboo
|
1.3K |
321K |
16 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
1.3K
|
321K
|
16
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
aboo
|
1.3K |
321K |
7 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
1.3K
|
321K
|
7
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
aboo
|
1.3K |
321K |
7 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
1.3K
|
321K
|
7
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
aboo
|
1.3K |
321K |
16 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
1.3K
|
321K
|
16
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
aboo
|
1.3K |
321K |
12 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
1.3K
|
321K
|
12
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
aboo
|
1.3K |
321K |
12 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
1.3K
|
321K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Positive Phase 1 MEND Study Top-Line Results
|
|
aboo
|
152 |
45K |
7 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
152
|
45K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Positive Phase 1 MEND Study Top-Line Results
|
|
aboo
|
152 |
45K |
3 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
152
|
45K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Positive Phase 1 MEND Study Top-Line Results
|
|
aboo
|
152 |
45K |
7 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
152
|
45K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Sparks Valuation Pharmaust
|
|
aboo
|
111 |
33K |
9 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
111
|
33K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Positive Phase 1 MEND Study Top-Line Results
|
|
aboo
|
152 |
45K |
9 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
152
|
45K
|
9
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Half Yearly Report and Accounts
|
|
aboo
|
147 |
33K |
2 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
147
|
33K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
aboo
|
114 |
33K |
9 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
114
|
33K
|
9
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Half Yearly Report and Accounts
|
|
aboo
|
147 |
33K |
2 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
147
|
33K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Presentation - Phase 1 Top-Line Results
|
|
aboo
|
34 |
10K |
23 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
34
|
10K
|
23
|
|